Analysis of correlation between thrombelastography and severity of coronary artery lesions in patients with acute coronary syndrome

doi:10.16150/j.1671-2870.2025.05.009

Abstract

Abstract:

Objective To investigate the correlation between thrombelastography (TEG) and the severity of coronary artery lesions in patients with acute coronary syndrome (ACS). Methods A total of 130 patients admitted to the Department of Cardiology of our hospital who underwent coronary angiography and had positive results were consecutively recruited as the ACS group. Meanwhile, 86 patients with ACS excluded by coronary angiography during the same period were selected as the control group. TEG parameters [reaction time (R time), clotting time (K time), blood clot formation rate (Angle α), maximum amplitude (MA)], triglycerides, total cholesterol, high-density lipoprotein, low-density lipoprotein, lactate dehydrogenase, and platelet levels were measured for all subjects. The differences in TEG indicators between the ACS group and control group were compared to identify potential risk factors for ACS. In ACS patients, the correlations of TEG parame-ters with laboratory-related indicators and the severity of coronary artery lesions assessed by the Gensini score were evalua-ted and analyzed. Logistic regression analysis was employed to evaluate the influencing factors of TEG in ACS patients with different numbers of coronary artery lesions. After adjusting for confounding factors, the independent predictive effect of TEG on the risk of ACS was further evaluated. Results The TEG parameters (R time and K time) in the ACS group were lower than those in the control group, and the difference was statistically significant (P<0.01). TEG parameters (R time and K time) were negatively correlated with the Gensini score (r_{R time}=-0.302 3, r_{K time}=-0.257 4, P<0.01). Multivariate logistic regression analysis showed that after adjusting for confounding factors, when TEG (K time) was considered as a categorical variable, Q4 (K time >2.10) was an independent protective factor against ACS (OR=0.34, 95% CI: 0.13-0.87, P<0.05). Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of R time and K time for diagnosing ACS was 0.781 0 and 0.605 1, respectively. The TEG parameter (R time) showed a sensitivity of 73.26% and a specificity of 70.00% for diagnosing ACS, while the K time showed a sensitivity of 65.38% and a specificity of 60.47%. Conclusion TEG is associated with ACS and the severity of coronary artery lesions and may serve as an independent predictor of the severity of coronary artery lesions in patients with ACS, which can provide a strong basis for determining whether further invasive diagnosis is needed.

Key words: Thrombelastography, Acute coronary syndrome, Coronary artery lesions

CLC Number:

XU Shen, SUN Ruizhuang, YU Qin, LIU Qukai, DING Ning. Analysis of correlation between thrombelastography and severity of coronary artery lesions in patients with acute coronary syndrome[J]. Journal of Diagnostics Concepts & Practice, 2025, 24(05): 534-541.

Figures/Tables 10

Table 1

Table 2

Table 3

Table 4

Table 5

Figure 1

Figure 2

Table 6

Table 7

Figure 3

References 23

[1]	ZHU Z, YU Y, HONG K, et al. Utility of viscoelastic hemostatic assay to guide hemostatic resuscitation in trauma patients: a systematic review[J]. World J Emerg Surg, 2022, 17(1):48. doi: 10.1186/s13017-022-00454-8 pmid: 36100918
[2]	BRILL J B, BRENNER M, DUCHESNE J, et al. The role of TEG and ROTEM in damage control resuscitation[J]. Shock, 2021, 56(1S):52-61. doi: 10.1097/SHK.0000000000001686 pmid: 33769424
[3]	NEAL M D, MOORE E E, WALSH M, et al. A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients[J]. J Trauma Acute Care Surg, 2020, 88(2):279-285. doi: 10.1097/TA.0000000000002545 pmid: 31738314
[4]	DAVID J S, JAMES A, ORION M, et al. Thromboe-lastometry-guided haemostatic resuscitation in severely injured patients: a propensity score-matched study[J]. Crit Care, 2023, 27(1):141.
[5]	SPASIANO A, BARBARINO C, MARANGONE A, et al. Early thromboelastography in acute traumatic coagulopathy: an observational study focusing on pre-hospital trauma care[J]. Eur J Trauma Emerg Surg, 2022, 48(1):431-439.
[6]	FALCINELLI E, DE PAOLIS M, BOSCHETTI E, et al. Release of MMP-2 in the circulation of patients with acute coronary syndromes undergoing percutaneous coronary intervention: Role of platelets[J]. Thromb Res, 2022, 216:84-89. doi: 10.1016/j.thromres.2022.06.006 pmid: 35759818
[7]	RAY A, NAJMI A, KHANDELWAL G, et al. Comparative effectiveness and safety of prasugrel and ticagrelor in patients of acute coronary syndrome undergoing percutaneous transluminal coronary angioplasty: A propensity score-matched analysis[J]. Indian Heart J, 2024, 76(2):133-135. doi: 10.1016/j.ihj.2024.03.001 pmid: 38485052
[8]	QIU G, LIN Y, OUYANG Y, et al. Nontargeted metabolomics revealed novel association between serum metabolites and incident acute coronary syndrome: A mendelian randomization study[J]. J Am Heart Assoc, 2023, 12(13):e028540.
[9]	SABATINE M S, BERGMARK B A, MURPHY S A, et al. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis[J]. Lancet, 2021, 398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5 pmid: 34793745
[10]	GOROG D A, LIP G Y H. Impaired Spontaneous/endo-genous fibrinolytic status as new cardiovascular risk factor?: JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 74(10):1366-1375.
[11]	SUMAYA W, WALLENTIN L, JAMES S K, et al. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy[J]. Eur Heart J, 2018, 39(13):1078-1085. doi: 10.1093/eurheartj/ehy013 pmid: 29390064
[12]	COLLET J P, THIELE H, BARBATO E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021, 42(14):1289-1367.
[13]	FARAG M, SPINTHAKIS N, GUE Y X, et al. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study[J]. Eur Heart J, 2019, 40(3):295-305. doi: 10.1093/eurheartj/ehy656 pmid: 30380032
[14]	LEE S H, KIM H K, AHN J H, et al. Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction[J]. Eur Heart J, 2023, 44(19):1718-1728. doi: 10.1093/eurheartj/ehad088 pmid: 36857519
[15]	SAITO Y, OYAMA K, TSUJITA K, et al. Treatment stra-tegies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond[J]. J Cardiol, 2023, 81(2):168-178.
[16]	DIFFERDING J A, UNDERWOOD S J, VAN P Y, et al. Trauma induces a hypercoagulable state that is resistant to hypothermia as measured by thrombelastogram[J]. Am J Surg, 2011, 201(5):587-591. doi: 10.1016/j.amjsurg.2011.01.012 pmid: 21545904
[17]	BHATT D L, LOPES R D, HARRINGTON R A. Diagnosis and treatment of acute coronary syndromes: A review[J]. JAMA, 2022, 327(7):662-675. doi: 10.1001/jama.2022.0358 pmid: 35166796
[18]	HOBSON A R, QURESHI Z, BANKS P, et al. Effects of clopidogrel on "aspirin specific" pathways of platelet inhibition[J]. Platelets, 2009, 20(6):386-390. pmid: 19811222
[19]	MOALLEMPOUR M, JAHR J S, LIM J C, et al. Methemoglobin effects on coagulation: a dose-response study with HBOC-200 (Oxyglobin) in a thrombelastogram model[J]. J Cardiothorac Vasc Anesth, 2009, 23(1):41-47. doi: 10.1053/j.jvca.2008.06.006 pmid: 18834828
[20]	PITTMAN J R, KOENIG A, BRAINARD B M. The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs[J]. J Vet Emerg Crit Care (San Antonio), 2010, 20(2):216-223.
[21]	VINAYAGAMOORTHY V, SRIVASTAVA A, DAS I, et al. Hypocoagulability in children with decompensated chronic liver disease and sepsis: assessment by thromboe-lastography[J]. JPGN Rep, 2023, 4(3):e324.
[22]	SCHOL P B B, LANGE N, HENSKENS Y, et al. Restrictive versus liberal fluid administration strategy (REFILL study) in postpartum hemorrhage and its effects on thromboelastometry (ROTEM®) values: a randomized, controlled trial[J]. J Int Med Res, 2023, 51(8):3000605231171007.
[23]	WAN H, FAN X, WU Z, et al. Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromes[J]. Thromb J, 2021, 19(1):33. doi: 10.1186/s12959-021-00288-5 pmid: 34022898

Degree of stenosis	≤25%	26%-50%	51%-75%	76%-90%	91%-99%	100%
Score	1	2	4	8	16	32
Location of lesion	LAC	proximal segment of LAD or LCX	mid-segment of LAD	mid-to-distal segment of LCX and the distal segment of LAD	RCA	branches of the coronary arteries
Disease coefficient	5	2.5	1.5	1	1	0.5

Item		Control group	ACS group	t/χ²	P
No. of participants[n (%)]		86 (41.20%)	130 (58.80%)
Gender	Male[n (%)]	55 (63.95%)	95 (73.08%)	1.43	0.154
Gender	Female[n (%)]	31 (36.05%)	35 (26.92%)	1.43	0.154
Age (years), mean ± SD		63.44 ± 11.08	63.00 ± 10.98	0.29	0.773
Laboratory results（mean ± SD）
R time (min)		6.99 ± 1.29	5.63 ± 1.25	7.75	<0.01
K time (min)		1.91 ± 0.46	1.75 ± 0.45	2.66	<0.01
Angle α (°)		64.84 ± 5.40	64.09 ± 5.88	0.94	0.35
MA (mm)		62.84 ± 4.76	63.35 ± 5.25	0.72	0.47
PLT (×10⁹/L)		202.36 ± 61.70	200.65 ± 55.72	0.21	0.83
TG (mmol/L)		1.41 ± 0.87	2.09 ± 2.40	2.50	<0.05
TC (mmol/L)		3.79 ± 1.04	4.25 ± 1.25	2.83	<0.01
HDL-C (mmol/L)		1.14 ± 0.29	1.13 ± 0.92	0.10	0.92
LDL-C (mmol/L)		2.31 ± 0.72	2.50 ± 0.89	1.63	0.11
LDH (U/L)		183.85 ± 71.14	242.88 ± 54.75	3.29	<0.01

Item	OR	95%CI	P
TG	1.52	1.09-2.11	0.013
TC	1.42	1.11-1.83	<0.01
HDL-C	0.98	0.68-1.41	0.92
LDL-C	1.33	0.94-1.87	0.12
LDH	1.006	1.002-1.009	<0.01
PLT	0.999	0.995-1.004	0.83
R time	0.43	0.33-0.56	<0.001
K time	0.43	0.23-0.82	0.01
Angle α	0.98	0.93-1.03	0.35
MA	1.02	0.97-1.08	0.47

Index	No. of lesion vessels	OR	95%CI	P
R time	Single-vessel lesion	Reference
	Double-vessel lesion	0.70	0.50-0.80	0.04
	Multi-vessel lesion	0.59	0.39-0.89	0.01
K time	Single-vessel lesion	Reference
	Double-vessel lesion	0.30	0.11-0.83	0.02
	Multi-vessel lesion	0.33	0.11-0.99	0.04
Angle α	Single-vessel lesion	Reference
	Double-vessel lesion	1.03	0.96-1.10	0.41
	Multi-vessel lesion	1.03	0.96-1.12	0.45
MA	Single-vessel lesion	Reference
	Double-vessel lesion	1.01	0.93-1.09	0.79
	Multi-vessel lesion	1.05	0.96-1.14	0.30

Group	Number of cases	R time (min)	K time (min)	Angle α (°)	MA (mm)
Single-vessel lesion	48	6.02 ± 1.25	1.87 ± 0.49	63.46 ± 5.69	62.92 ± 4.85
Double-vessel lesion	45	5.44 ± 1.34	1.68 ± 0.36	64.49 ± 6.38	63.20 ± 5.58
Multi-vessel lesion	37	5.34 ± 1.02	1.65 ± 0.33	64.43 ± 5.57	64.09 ± 5.41
F		4.04	4.03	0.44	0.54
P		0.02	0.02	0.64	0.58